Lytix Biopharma AS
🇳🇴Norway
- Country
- 🇳🇴Norway
- Ownership
- Public
- Established
- 2003-01-01
- Employees
- 11
- Market Cap
- -
Verrica Pharmaceuticals Reports Record Growth in YCANTH® Dispensed Units for Molluscum Contagiosum Treatment
• Verrica Pharmaceuticals achieved a milestone with over 10,000 YCANTH® dispensed applicator units in Q1 2025, representing a 16.7% sequential increase from the previous quarter.
• The company reports normalized distribution inventory levels, indicating that dispensed units will now more closely track actual demand and gross revenue.
• Following a commercial restructuring, Verrica is positioned for sustainable revenue growth as it works to establish YCANTH® as the standard of care for molluscum contagiosum.
© Copyright 2025. All Rights Reserved by MedPath